Corroborating the ability to fulfill a tumor-promoting function in osteosarcoma, Spry3 proteins are heavily overexpressed in this bone tumor-derived cancer, while it is hardly detectable in normal human osteoblasts. This evidence concerns the gene SPRY3 and neoplasm.